Table 2 Carcinoma-related treatment of patients with diabetes in group of patients on glargine and other types of insulin
Factor | Subgroup | Patients on glargine | Patients on other types of insulin | p-value |
|---|---|---|---|---|
(N = 13) | (N = 66) | |||
Breast surgical procedure | Quadrantectomy or lumpectomy Mastectomy | 7 | 23 | 0.20 |
6 | 43 | |||
Axillary surgical procedure | Sentinel node biopsy | 5 | 24 | 0.78 |
Lymphadenectomy | 8 | 42 | ||
Adjuvant Chemotherapy | No | 9 | 50 | 0.72 |
Yes | 4 | 16 | ||
Adjuvant Hormone therapy | No | 3 | 6 | 0.17 |
Yes | 10 | 60 | ||
Adjuvant Trastuzumab | No | 13 | 62 | 1.00 |
Yes | 0 | 4 | ||
Adjuvant Radiotherapy | No | 5 | 32 | 0.49 |
Yes | 8 | 34 | ||
Outcome | Alive | 13 | 63 | 1.00 |
Died of disease | 0 | 3 |